Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.3B | 2.1B | 2.1B | 2.1B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 311.4M | 333.3M | 375.9M | 367.5M |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 795.1M | 767.5M | 723.8M | 725.4M |
Tax provision | 237.9M | 214.8M | 170.4M | 238.1M |
Net income | 557.2M | 552.6M | 553.4M | 487.3M |
Basic EPS | 0.1 | — | 0.1 | 0.1 |
Diluted EPS | 0.1 | — | 0.1 | 0.1 |
Basic average shares | 5.4B | — | 5.4B | 5.4B |
Diluted average shares | 5.5B | — | 5.5B | 5.5B |
EBITDA | — | — | — | — |
Net income from continuing op. | 557.2M | 552.6M | 553.4M | 487.3M |
Minority interests | -5K | — | — | — |
Preferred stock dividends | — | — | — | — |